JPH0523743B2 - - Google Patents
Info
- Publication number
- JPH0523743B2 JPH0523743B2 JP25543090A JP25543090A JPH0523743B2 JP H0523743 B2 JPH0523743 B2 JP H0523743B2 JP 25543090 A JP25543090 A JP 25543090A JP 25543090 A JP25543090 A JP 25543090A JP H0523743 B2 JPH0523743 B2 JP H0523743B2
- Authority
- JP
- Japan
- Prior art keywords
- dna
- plasmid
- add
- fragment
- reaction solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000013612 plasmid Substances 0.000 claims description 32
- 241000588724 Escherichia coli Species 0.000 claims description 23
- 210000004185 liver Anatomy 0.000 claims description 13
- 102000018832 Cytochromes Human genes 0.000 claims description 2
- 108010052832 Cytochromes Proteins 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims 1
- 108020004414 DNA Proteins 0.000 description 40
- 239000000243 solution Substances 0.000 description 37
- 238000006243 chemical reaction Methods 0.000 description 36
- 239000012634 fragment Substances 0.000 description 32
- 108091008146 restriction endonucleases Proteins 0.000 description 21
- 101710104049 Cytochrome P450 1A1 Proteins 0.000 description 18
- 102100031476 Cytochrome P450 1A1 Human genes 0.000 description 14
- 238000000034 method Methods 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 9
- 238000010276 construction Methods 0.000 description 7
- 238000001962 electrophoresis Methods 0.000 description 7
- 239000013613 expression plasmid Substances 0.000 description 7
- 238000002844 melting Methods 0.000 description 7
- 230000008018 melting Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 102000012410 DNA Ligases Human genes 0.000 description 6
- 108010061982 DNA Ligases Proteins 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 108091081024 Start codon Proteins 0.000 description 6
- 239000011543 agarose gel Substances 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 6
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 5
- 239000013604 expression vector Substances 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 229920000936 Agarose Polymers 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 239000012133 immunoprecipitate Substances 0.000 description 3
- 238000007169 ligase reaction Methods 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 101710163270 Nuclease Proteins 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 239000007984 Tris EDTA buffer Substances 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- XNCSCQSQSGDGES-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]propyl-(carboxymethyl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)C(C)CN(CC(O)=O)CC(O)=O XNCSCQSQSGDGES-UHFFFAOYSA-N 0.000 description 1
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 1
- DYDCUQKUCUHJBH-UWTATZPHSA-N D-Cycloserine Chemical compound N[C@@H]1CONC1=O DYDCUQKUCUHJBH-UWTATZPHSA-N 0.000 description 1
- DYDCUQKUCUHJBH-UHFFFAOYSA-N D-Cycloserine Natural products NC1CONC1=O DYDCUQKUCUHJBH-UHFFFAOYSA-N 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 241001452028 Escherichia coli DH1 Species 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 102000008015 Hemeproteins Human genes 0.000 description 1
- 108010089792 Hemeproteins Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- PPQNQXQZIWHJRB-UHFFFAOYSA-N Methylcholanthrene Chemical compound C1=CC=C2C3=CC4=CC=C(C)C(CC5)=C4C5=C3C=CC2=C1 PPQNQXQZIWHJRB-UHFFFAOYSA-N 0.000 description 1
- 101100301239 Myxococcus xanthus recA1 gene Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000002962 chemical mutagen Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 229960003077 cycloserine Drugs 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 239000010842 industrial wastewater Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000006241 metabolic reaction Methods 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000003228 microsomal effect Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- BHZOKUMUHVTPBX-UHFFFAOYSA-M sodium acetic acid acetate Chemical compound [Na+].CC(O)=O.CC([O-])=O BHZOKUMUHVTPBX-UHFFFAOYSA-M 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Description
【発明の詳細な説明】
本発明は、ラツト肝チトクロムP−450cの製造
方法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing rat liver cytochrome P-450c.
3−メチルコラントレン投与により誘導される
ラツト肝チトクロムP−450cは、還元型で一酸化
炭素と結合し、その差スペクトルが447nmに吸収
極大を示すヘム蛋白質であり、ステロイドや脂肪
酸の代謝、外来の脂溶性有機化合物の酸化的代謝
反応あるいは化学変異剤の代謝活性化などに関与
している。本発明は、この高い水酸化活性を有
し、しかも基質特異性の幅が広いチトクロムP−
450cを大腸菌で発現させ、工業的なレベルでの酸
化反応過程や産業排水中の有機化合物の酸化除去
等に応用することを可能にする大腸菌内発現用の
プラスミドを提供するものである。 Rat liver cytochrome P-450c, which is induced by administration of 3-methylcholanthrene, is a heme protein that binds to carbon monoxide in its reduced form, and its difference spectrum shows an absorption maximum at 447 nm. It is involved in the oxidative metabolic reactions of fat-soluble organic compounds and the metabolic activation of chemical mutagens. The present invention utilizes cytochrome P, which has high hydroxylation activity and a wide range of substrate specificity.
The present invention provides a plasmid for expressing 450c in Escherichia coli, which makes it possible to apply it to oxidation reaction processes at an industrial level, oxidative removal of organic compounds in industrial wastewater, etc.
近年、高等生物由来の生理活性ペチプドをコー
ドするcDNAあるいは合成DNAにプロモータを
接続することにより構築したプラスミドを大腸菌
に導入し、生理活性ペプチドを大腸菌に発現させ
た例は少なくない。インスリン、成長ホルモン、
インターフエロン等は工業的レベルでの微生物生
産が試みられている。しかしながら、細胞のミク
ロソーム膜に局在し、分子量も59300ダルトンと
大きくしかも蛋白分子内にヘムを含有しているチ
トクロムP−450cについては、現在のところ大腸
菌内で発現を行つた報告はない。 In recent years, there have been many cases in which a plasmid constructed by connecting a promoter to a cDNA encoding a bioactive peptide derived from a higher organism or a synthetic DNA was introduced into E. coli, and the bioactive peptide was expressed in E. coli. insulin, growth hormone,
Attempts have been made to produce interferon and the like using microorganisms at an industrial level. However, as for cytochrome P-450c, which is localized in the microsomal membrane of cells, has a large molecular weight of 59,300 daltons, and contains heme in the protein molecule, there is currently no report on its expression in E. coli.
本発明の大腸菌内発現を目的とした組換え体プ
ラスミドpMG1は、強力プロモーターであるtac
プロモーターの下流に、高い酸化活性を示すラツ
ト肝のチトクロムP−450c遺伝子が連結してい
る。さらに、大腸菌での発現を調節する転写因子
であるSD配列やSD配列と開始コドン間の距離等
も十分満たされている。 The recombinant plasmid pMG1 of the present invention intended for expression in E. coli has a strong promoter, tac.
The rat liver cytochrome P-450c gene, which exhibits high oxidative activity, is linked downstream of the promoter. Furthermore, the SD sequence, which is a transcription factor that regulates expression in E. coli, and the distance between the SD sequence and the start codon, etc., are sufficiently satisfied.
取得したpMG1プラスミドを用いて大腸菌を形
質転換することにより、大腸菌細胞内にラツト肝
チトクロムP−450cが合成され、それを分離、精
製することができる。このようにして、得られた
チトクロムP−450c標品とラツト肝のNADPH
−チトクロムP−450c還元酵素をともに同時固定
化し、酸化反応を行わせることが可能である。ま
た、産生チトクロムP−450cを分離、精製せず、
酸化反応を司どる大腸菌として、固定化しバイオ
リアクターとして応用することもでき、また、活
性汚泥に加えることも可能である。 By transforming E. coli using the obtained pMG1 plasmid, rat liver cytochrome P-450c is synthesized within the E. coli cells, and it can be isolated and purified. In this way, the obtained cytochrome P-450c specimen and rat liver NADPH
- It is possible to simultaneously immobilize cytochrome P-450c reductase and perform an oxidation reaction. In addition, the produced cytochrome P-450c is not separated or purified,
As Escherichia coli controls the oxidation reaction, it can be immobilized and applied as a bioreactor, and it can also be added to activated sludge.
本発明の組換えプラスミドpMG1は、組換えプ
ラスミドpAU157(Nucl.Acids.Res.12,p2929−
29 38に記載の方法で製造できる。)を大腸菌の強
力プロモーターであるtacプロモーターに接続す
ることにより構築できる。 The recombinant plasmid pMG1 of the present invention is a recombinant plasmid pAU157 (Nucl. Acids. Res. 12 , p2929-
29 Can be produced by the method described in 38. ) can be constructed by connecting it to the tac promoter, a strong E. coli promoter.
tacプロモーターは、trpプロモーターの“−35
領域”とlacUV5プロモーターの“−10領域”か
ら構成されている大腸菌の強力プロモーターの1
つである。 The tac promoter is “−35” of the trp promoter.
One of the strong promoters of E. coli, consisting of the “-10 region” of the lacUV 5 promoter.
It is one.
次に実施例により本発明について詳細に説明す
る。 Next, the present invention will be explained in detail with reference to Examples.
実施例
ラツト肝チトクロムP−450c遺伝子の大腸菌内
発現を目的とした発現用プラスミドpMG1の構
築
ラツト肝チトクロムP−450c蛋白質の全コーデ
イング領域をもつ組換え体プラスミドpAU157
(Nucl.Acids.Res.12,p2929−29 38に記載の方法
で製造できる。)より単離したチトクロムP−
450cの構造遺伝子を、大腸菌の強力プロモーター
であるtacプロモーター(P.L.バイオケミカル社)
に接続し、大腸菌内発現用プラスミドpMG1を以
下のように構築した。Example Construction of expression plasmid pMG1 for expression of rat liver cytochrome P-450c gene in E. coli Recombinant plasmid pAU157 containing the entire coding region of rat liver cytochrome P-450c protein
(Can be produced by the method described in Nucl.Acids.Res. 12 , p2929-2938).
The structural gene of 450c was transferred to the tac promoter (PL Biochemical Co., Ltd.), a strong E. coli promoter.
A plasmid pMG1 for expression in E. coli was constructed as follows.
I 発現ベクターpDG1の構築
発現用プラスミドpMG1構築の第一段階とし
て、tacプロモーターを保持する発現ベクター
pDR540(PLバイオケミカル社)を改変し、新た
な発現ベクターpDG1を構築した。以下に、2つ
のステツプに分け、その構築の方法を述べる。I Construction of expression vector pDG1 As the first step in constructing expression plasmid pMG1, an expression vector carrying the tac promoter was constructed.
A new expression vector pDG1 was constructed by modifying pDR540 (PL Biochemical). Below, we will explain how to construct it in two steps.
ステツプ1:pDR540プラスミドの部分的分解
1μgのpDR540プラスミドDNAに、2ユニツト
の制限酵素BamHI(宝酒造)を加え、10μの
BamHI反応液〔10mMTris−HC(pH8.0),
7mM MgC2,100mM NaC,2mM−メルカ
プトエタノール,0.01%ウシ血清アルブミン〕中
で37℃1時間反応した。つぎにこの反応液に1ユ
ニツトのS1ヌクレース(PLバイオケミカル社)
および10μのS1ヌクレース反応液
〔100mMNaOAc−HOAc(PH4.0),300mM
NaC,12mMZnSO4〕を加え、さらに18℃で2
時間反応させた。反応後、反応液に等量のフエノ
ール−クロロホルム溶液〔フエノール:クロロホ
ルム(1:1)〕を加え、混合し、10000rpmで5
分間遠心後、上澄を分取した。つぎに、2倍量の
冷エタノールを加えて、−80℃に15分間放置した
後、10000rpmで10分間遠心し、DNAを回収し、
10μの蒸留水に懸濁した。Step 1: Partial digestion of pDR540 plasmid Add 2 units of restriction enzyme BamHI (Takara Shuzo) to 1μg of pDR540 plasmid DNA, and digest with 10μg of pDR540 plasmid DNA.
BamHI reaction solution [10mMTris-HC (pH8.0),
The reaction was carried out at 37°C for 1 hour in 7mM MgC 2 , 100mM NaC, 2mM mercaptoethanol, 0.01% bovine serum albumin. Next, add 1 unit of S1 nuclease (PL Biochemical Co., Ltd.) to this reaction solution.
and 10μ S1 nuclease reaction solution [100mM NaOAc-HOAc (PH4.0), 300mM
NaC, 12mMZnSO 4 ] and then heated to 18℃ for 2 hours.
Allowed time to react. After the reaction, an equal amount of phenol-chloroform solution [phenol:chloroform (1:1)] was added to the reaction solution, mixed, and heated at 10,000 rpm for 5 minutes.
After centrifugation for a minute, the supernatant was collected. Next, add twice the volume of cold ethanol, leave at -80°C for 15 minutes, and centrifuge at 10,000 rpm for 10 minutes to collect DNA.
Suspended in 10μ of distilled water.
ステツプ2:pDG1の構築
ステツプ1で調製した10μのDNA溶液に1μg
の Bgリンカー(宝酒造)および4ニツト
のT4DNAリガーゼ(宝酒造)を加え、20μの
T4DNAリガーゼ反応液〔66mMTris−HC
(pH7.6),6.6mMMgC 2.
10mMdithiothreito,1.0mMATP〕中で16℃
15時間反応させた。反応後、反応液をCohenらの
方法(Proc.Nat.Acad.Sci.U.S.A.69,p2110
−2114)を用いて、大腸菌(Escherichiacoli)
DH1株(F-,recA1,endA1,gyrA96,thi−
1,hsdR17,supE44,λ-,九州大学医学部遺伝
情報施設保存菌株・住友化学工業株式会社宝塚総
合研究所にても保存)に形質転換し、100μg/ml
のアンピシリン(シグマ社)を含むLBプレート
(1当り10gのポリペプトン,5gのイーストエ
キストラクト,5gのNaC,12gの寒天を含む)
に形質転換体を広げ、出現したコロニーを単離し
た。つぎに、Birnboimらの方法(Nucl,Acids,
Res,7,p−1513−1523)に従つて、コロニー
よりプラスミドDNAを調製し、1μgのプラスミ
ドDNAに対し、1ユニツトの制限酵素Bgを
加えて、Bg反応液〔10mMTris−HC
(PH7.5),7mMMgC2,100mM NaC,
7mM2−メルカプトエタノール〕中で、37℃、1
時間反応した。反応後、反応液を0.1μg/mlの臭
化エチジウム(アルドリツチ社)を含む1.0%の
アガロースゲル(シグマ社)に供し、100Vで60
分間電気泳動した。紫外線ランプ下で泳動パター
ンを観察し、制限酵素Bgで1カ所切断を受
けたプラスミドを選択し、pDG1プラスミドと名
付けた。構築した発現ベクターは、tacプロモー
ターを保持し、SD配列の下流7塩基に、制限酵
素Bgの認識部位を持つており、この部位に
目的のDNA断片を組込むことにより、目的蛋白
質の発現を行うことができる。Step 2: Construction of pDG1 Add 1 μg to the 10 μ DNA solution prepared in Step 1.
of Bg linker (Takara Shuzo) and 4 nits of T 4 DNA ligase (Takara Shuzo), and
T 4 DNA ligase reaction solution [66mMTris-HC
(pH7.6), 6.6mMMgC 2 .
10mMdithiothreito, 1.0mMATP] at 16℃
The reaction was allowed to proceed for 15 hours. After the reaction, the reaction solution was processed using the method of Cohen et al. (Proc. Nat. Acad. Sci. USA 69 , p2110).
−2114) using Escherichia coli (Escherichia coli).
DH1 strain ( F- , recA1, endA1, gyrA96, thi-
1, hsdR17, supE44, λ - , strain stored at Kyushu University School of Medicine Genetic Information Facility, also stored at Takarazuka Research Institute, Sumitomo Chemical Co., Ltd.) and transformed into 100 μg/ml.
LB plates containing ampicillin (Sigma) (each containing 10 g polypeptone, 5 g yeast extract, 5 g NaC, 12 g agar)
The transformants were spread and the colonies that appeared were isolated. Next, Birnboim et al.'s method (Nucl, Acids,
Res, 7 , p-1513-1523), plasmid DNA was prepared from the colony, 1 unit of restriction enzyme Bg was added to 1 μg of plasmid DNA, and Bg reaction solution [10mM Tris-HC
(PH7.5), 7mMgC 2 , 100mM NaC,
7mM mercaptoethanol] at 37°C for 1
Time reacted. After the reaction, the reaction solution was applied to a 1.0% agarose gel (Sigma) containing 0.1 μg/ml ethidium bromide (Aldrich) and incubated at 100 V for 60 min.
Electrophoresis was performed for minutes. The migration pattern was observed under an ultraviolet lamp, and a plasmid cleaved at one site with restriction enzyme Bg was selected and named pDG1 plasmid. The constructed expression vector retains the tac promoter and has a recognition site for the restriction enzyme Bg at 7 bases downstream of the SD sequence, and by integrating the target DNA fragment into this site, the target protein can be expressed. I can do it.
tacプロモーターとチトクロムP−450cの開
始コドンを含むDNAの結合(pDGN101の構築)
発現用プラスミドpMG1構築の第二段階とし
て、で構築した発現ベクターpDG1より、tac
プロモーターを含むEcoRI−BeDNA断片を
単離し、これに、チトクロムP−450遺伝子の開
始コドンを含む約300塩基対のSau3A−Pst
断片を接続し、組換え体プラスミドpDGN101を
得た。以下、4つのステツプに分け、その構築の
方法を述べる。 Binding of DNA containing the tac promoter and the start codon of cytochrome P-450c (construction of pDGN101) As the second step in constructing the expression plasmid pMG1, tac
An EcoRI-BeDNA fragment containing the promoter was isolated, and this was combined with an approximately 300 base pair Sau3A-Pst fragment containing the start codon of the cytochrome P-450 gene.
The fragments were ligated to obtain a recombinant plasmid pDGN101. Below, we will explain how to construct it, dividing it into four steps.
ステツプ1:3600塩基対のEcoR−Pst断片
の調製
1μgのpBR322DNA(和光純薬)に、1ユニツ
トの制限酵素EcoR(宝酒造)および1ユニツ
トの制限酵素Pst(宝酒造)を加え、20μの
EcoR反応液〔100mM Tris−HC,(PH7.5)、
7mMMgC2,50mM NaC,7mM2−メルカ
プトエタノール,0.01%ウシ血清アルブミン〕中
で37℃1時間反応した。反応後。反応液を
0.1μg/mlの臭化エチジウムを含む1.0%の低融点
アガロースゲル(ベセスダ・リサーチ社)に供
し、電気泳動を行つた。泳動後、紫外線ランプ下
で、3.6KbのEcoR−PstDNA断片に相当す
るゲル部分を切り出し、エツペンドルフ管にと
り、65℃で5分間加熱した。融解したゲルに2倍
量のTE緩衝液〔10mMTris−HC(PH8.0),
0.5mMEDTA〕を加え、次にTE緩衝液で飽和し
たフエノールを加えて、フエノール抽出を行つ
た。10000r.p.m.で5分間遠心し、上層を分取し
た後、1/40量の4MNaCおよび2倍量のエタノ
ールを加えて−80℃に10分間放置することにより
DNAをエタノール沈殿した。その後10000rpmで
10分間遠心し、約0.2μgの3.6Kb EcoR−P st
DNA断片を回収し、10μの蒸留水に懸濁し
た。Step 1: Preparation of 3600 base pair EcoR-Pst fragment Add 1 unit of restriction enzyme EcoR (Takara Shuzo) and 1 unit of restriction enzyme Pst (Takara Shuzo) to 1 μg of pBR322DNA (Wako Pure Chemical Industries),
EcoR reaction solution [100mM Tris-HC, (PH7.5),
7mMgC 2 , 50mM NaC, 7mM 2-mercaptoethanol, 0.01% bovine serum albumin] at 37°C for 1 hour. After reaction. reaction solution
Electrophoresis was performed using a 1.0% low melting point agarose gel (Bethesda Research) containing 0.1 μg/ml ethidium bromide. After electrophoresis, the gel portion corresponding to the 3.6 Kb EcoR-Pst DNA fragment was cut out under an ultraviolet lamp, placed in an Eppendorf tube, and heated at 65° C. for 5 minutes. Add twice the volume of TE buffer to the melted gel [10mM Tris-HC (PH8.0),
Phenol extraction was performed by adding 0.5mM MEDTA] and then adding phenol saturated with TE buffer. Centrifuge at 10,000 rpm for 5 minutes, separate the upper layer, add 1/40 volume of 4M NaC and 2 volumes of ethanol, and leave at -80℃ for 10 minutes.
DNA was ethanol precipitated. then at 10000rpm
Centrifuge for 10 minutes and collect approximately 0.2μg of 3.6Kb EcoR-P st
DNA fragments were collected and suspended in 10μ of distilled water.
ステツプ2 tacプロモーター断片の調製
1μgの発現ベクターpDG1に、1ユニツトの制
限酵素EcoRおよび1ユニツトの制限酵素Bg
を加え、20μのEcoR反応液中で37℃1時
間反応した。反応後、ステツプ1と同様の操作に
より、低融点アガロース電気泳動を行い、約420
塩基のEcoR−BgDNA断片をゲルより切
り出し、DNAを回収し、10μの蒸留水に懸濁
した。Step 2 Preparation of tac promoter fragment Add 1 unit of restriction enzyme EcoR and 1 unit of restriction enzyme Bg to 1 μg of expression vector pDG1.
was added and reacted for 1 hour at 37°C in a 20μ EcoR reaction solution. After the reaction, perform low melting point agarose electrophoresis using the same procedure as in step 1.
The base EcoR-Bg DNA fragment was excised from the gel, the DNA was collected, and suspended in 10μ of distilled water.
ステツプ3 チトクロムP−450c遺伝子の開始
コドンを含むSau3A1−Pst断片の調製
5μgのpAU157DNAに、5ユニツトの制限酵素
Pstを加え、20μのPst反応液〔20mM Tris
−HC(PH7.5),10mMMgC2,50mM
(NH4)2SO4,0.01%ウシ血清アルブミン〕中で
37℃1時間反応し、低融点アガロース電気泳動
後、約300塩基対のPstDNA断片を切り出し、
DNA回収後、10μの蒸留水に懸濁した。なお、
このDNA断片中にあるSau3A1切断部位の4塩
基下流にチトクロムP−450c遺伝子の開始コドン
が存在していることが判明している。そこで、こ
のPstDNA断片を含む溶液に、3ユニツトの制
限酵素Sau3A1(宝酒造)を加え、20μの
Sau3A1反応液〔10mMTris−HC(pH7.5),
7mM MgC2,100mM NaC〕中で37℃1時
間反応させ、等量のフエノールークロロホルム溶
液で処理後、DNAを回収し、10μの蒸留水に
懸濁した。Step 3 Preparation of Sau3A1-Pst fragment containing the start codon of cytochrome P-450c gene Add 5 units of restriction enzyme to 5 μg of pAU157 DNA.
Add Pst and add 20μ of Pst reaction solution [20mM Tris
−HC (PH7.5), 10mMgC 2 , 50mM
(NH 4 ) 2 SO 4 , 0.01% bovine serum albumin]
After reacting at 37°C for 1 hour and performing electrophoresis on low melting point agarose, a PstDNA fragment of approximately 300 base pairs was excised.
After DNA collection, it was suspended in 10μ of distilled water. In addition,
It has been found that the initiation codon of the cytochrome P-450c gene is present 4 bases downstream of the Sau3A1 cleavage site in this DNA fragment. Therefore, we added 3 units of the restriction enzyme Sau3A1 (Takara Shuzo) to the solution containing this PstDNA fragment, and added 20μ of the restriction enzyme Sau3A1 (Takara Shuzo).
Sau3A1 reaction solution [10mMTris-HC (pH7.5),
After reacting for 1 hour at 37°C in 7mM MgC 2 , 100mM NaC] and treating with an equal volume of phenol-chloroform solution, the DNA was collected and suspended in 10μ of distilled water.
ステツプ4 組換え体プラスミドpDGN101の
構築
ステツプ1・2・3で調製した、3600塩基対の
EcoR−PstDNA断片、400塩基対のEcoR
−BgDNA断片および開始コドンを保持する
Sau3A1−PstDNA断片混液をそれぞれ0.2μgづ
つ混合し、7.2ユニツトのT4DNAリガーゼを加
え、45μのT4DNAリガーゼ反応液中で16°C2時
間反応した。その後、Cohenらの方法に従い、反
応液で大腸菌DH1株を形質転換した。形質転換
体をRutherらの方法(Mo.Gen.Genetics
178,P475−477)に従い、200μg/mlの5−ブロ
ム−4−クロル−3−インドリル−β−D−ガラ
クトシド(半井化学)、および15μg/mlのテトラ
サイクリン(シグマ社)を含むLBプレートに広
げ、出現した青色コロニーを単離した。前述の
Birnboimらの方法に従い、コロニーよりプラス
ミドDNAを調製し、2μgのプラスミドDNAに対
し、2ユニツトの制限酵素Hind(宝酒造)お
よび2ユニツトの制限酵素Bg(ニツポンジ
ーン)を加え、20μのHind反応液中で37℃1
時間反応した。反応液を1.0%アガロースゲル電
気泳動で分析し、2300塩基対、900塩基対、450塩
基対、350塩基対および250塩基対の5つのDNA
断片が検出されるプラスミドを選択し、
pDGN101とした。Step 4 Construction of recombinant plasmid pDGN101 The 3600 base pair plasmid prepared in Steps 1, 2, and 3
EcoR−PstDNA fragment, 400 base pairs of EcoR
- Retains BgDNA fragment and start codon
0.2 μg of each Sau3A1-Pst DNA fragment mixture was mixed, 7.2 units of T 4 DNA ligase was added, and the mixture was reacted in a 45 μg T 4 DNA ligase reaction solution at 16° C. for 2 hours. Thereafter, E. coli strain DH1 was transformed with the reaction solution according to the method of Cohen et al. Transformants were prepared using the method of Ruther et al. (Mo. Gen. Genetics
178, P475-477), spread on LB plates containing 200 μg/ml 5-bromo-4-chloro-3-indolyl-β-D-galactoside (Hani Chemical) and 15 μg/ml tetracycline (Sigma). , the blue colonies that appeared were isolated. mentioned above
Plasmid DNA was prepared from colonies according to the method of Birnboim et al., and 2 units of restriction enzyme Hind (Takara Shuzo) and 2 units of restriction enzyme Bg (Nippon Gene) were added to 2 μg of plasmid DNA and added to 20 μg of Hind reaction solution. at 37℃1
Time reacted. The reaction solution was analyzed by 1.0% agarose gel electrophoresis, and five DNAs of 2300 base pairs, 900 base pairs, 450 base pairs, 350 base pairs, and 250 base pairs were detected.
Select the plasmid for which the fragment is detected,
It was named pDGN101.
発現用プラスミドpMG1の構築
で構築した組換え体プラスミドpDGN101お
よびpAU157プラスミドとpBR322プラスミドか
ら、発現用プラスミドpMG1を構築した。以下、
4つのステツプに分け、構築の方法について述べ
る。 Construction of expression plasmid pMG1 Expression plasmid pMG1 was constructed from the recombinant plasmids pDGN101 and pAU157 plasmids and pBR322 plasmid constructed in the above. below,
The construction method will be explained in four steps.
ステツプ1 300塩基のHind−Pst断片の
調製
2μgのpDGN101プラスミドに、2ユニツトの
制限酵素Hindを加え、20μのHind反応液
中で37℃1時間反応し、1.0%低融点アガロース
電気泳動を行い、3900塩基対のHindDNA断片
を単離した。つぎにこのDNA溶液に、2ユニツ
トの制限酵素Pstを加え、20μのPst反応液
中で37℃1時間反応し、同様の操作により、tac
プロモーターを含む300塩基対のHind−Pst
DNA断片を調製した。このDNAを、以後、
DNA断片aと呼ぶ。Step 1 Preparation of 300 base Hind-Pst fragment Add 2 units of restriction enzyme Hind to 2 μg of pDGN101 plasmid, react in 20 μg of Hind reaction solution at 37°C for 1 hour, perform electrophoresis on 1.0% low melting point agarose, A 3900 base pair HindDNA fragment was isolated. Next, 2 units of restriction enzyme Pst were added to this DNA solution, and the reaction was carried out for 1 hour at 37°C in a 20μ Pst reaction solution.
300 base pair Hind-Pst containing promoter
DNA fragments were prepared. From now on, this DNA
It is called DNA fragment a.
ステツプ2 Pvu−HincDNA断片および
Pst−HincDNA断片の調製
5μgのpAU157プラスミドDNAに5ユニツトの
制限酵素Pvu(バイオラボ社)を加え、20μ
のPvu反応液〔7mMTris−HC(PH7.4)、
150mM NaC、6mMgC2、6mM2−メルカプ
トエタノール、100μg/mlウシ血清アルブミン〕
中で37℃1時間反応し、DNAを回収した。引き
つづき、このDNA溶液に5ユニツトの制限酵素
Hinc(宝酒造)を加え、20μのHinc反応
液〔10mMTris−HC(PH8.0)、7mMMgC
2、60mM NaC、7mM2−メルカプトエタノー
ル〕中で37℃1時間反応し、1.0%の低融点アガ
ロースゲルで電気泳動後、3200塩基対のPvu−
HincDNA断片を単離した(DNA断片bとす
る。)
また、同時に2100塩基対のHincDNA断片を
同様の方法で調製し、引きつづきこのDNA溶液
に3ユニツトの制限酵素Pstを加え、20μの
Pst反応液中で37℃1時間反応した。得られた
反応生成物を1.0%の低融点アガロースゲルで分
離し、1000塩基対のPst−HincDNA断片を
単離した(DNA断片cとする。)
ステツプ3 700塩基対のHind−Pvu
DNA断片の調製
2μgのpBR322DNAに2ユニツトの制限酵素
Pvuを加え、20μのPvu反応液中で37℃1
時間反応し、DNAを回収した。次いでこのDNA
溶液に2ユニツトの制限酵素Hindを加え、20μ
のHind反応液中で37℃1時間反応した。反
応生成物を、1.0%低融点アガロースゲルで分離
し、700塩基対のPvu−HindDNA断片を単
離した(DNA断片dとする。)
ステツプ4
ステツプ1・2・3で調製したDNAを各々約
0.2μgづつ混合し、3ユニツトのT4DNAリガー
ゼを加え、30μのT4DNAリガーゼ反応液中で
16℃15時間反応した。反応後、反応液で大腸菌
DH1株を形質転換し、200μg/mlの5−ブロム−
4−クロル−3−インドリル−β−D−ガラクト
シドおよび10μg/mlのアンピシリン(シグマ社)
を含むLBプレートに広げ、出現した青色コロニ
ーを単離した。コロニーよりプラスミドDNAを
調製し、1μgのプラスミドDNAに対して1ユニ
ツトの制限酵素Hincを加えて、20μのHind
反応液中で37℃1時間反応させた後、反応生成
物を1.0%のアガロースゲルで分析した。分析し
たプラスミドのうち、3300塩基対、500塩基対お
よび1300塩基対のDNA断片が検出されプラスミ
ドを選択し、pMG1と名付けた。Step 2 Pvu-HincDNA fragment and
Preparation of Pst-HincDNA fragment Add 5 units of restriction enzyme Pvu (Bio-Lab) to 5 μg of pAU157 plasmid DNA,
Pvu reaction solution [7mMTris-HC (PH7.4),
150mM NaC, 6mMgC 2 , 6mM 2-mercaptoethanol, 100μg/ml bovine serum albumin]
The mixture was reacted for 1 hour at 37°C, and the DNA was collected. Next, add 5 units of restriction enzyme to this DNA solution.
Add Hinc (Takara Shuzo) and add 20μ of Hinc reaction solution [10mM Tris-HC (PH8.0), 7mMgC
2 , 60mM NaC, 7mM2-mercaptoethanol] at 37℃ for 1 hour, and after electrophoresis on a 1.0% low melting point agarose gel, a 3200 base pair Pvu-
A HincDNA fragment was isolated (referred to as DNA fragment b). At the same time, a 2100 base pair HincDNA fragment was prepared in the same manner, and 3 units of restriction enzyme Pst were added to this DNA solution, and 20μ
The reaction was carried out in the Pst reaction solution at 37°C for 1 hour. The obtained reaction product was separated on a 1.0% low melting point agarose gel, and a 1000 base pair Pst-Hinc DNA fragment was isolated (referred to as DNA fragment c) Step 3: 700 base pair Hind-Pvu
Preparation of DNA fragment: Add 2 units of restriction enzyme to 2 μg of pBR322 DNA.
Add Pvu and incubate at 37°C in 20μ Pvu reaction solution.
After a time reaction, DNA was collected. Then this DNA
Add 2 units of restriction enzyme Hind to the solution and add 20μ
The mixture was reacted for 1 hour at 37°C in the Hind reaction solution. The reaction products were separated on a 1.0% low melting point agarose gel, and a 700 base pair Pvu-Hind DNA fragment was isolated (referred to as DNA fragment d). Step 4 The DNA prepared in Steps 1, 2, and 3 was separated into approximately
Mix 0.2 μg each, add 3 units of T 4 DNA ligase, and mix in 30 μg of T 4 DNA ligase reaction solution.
The reaction was carried out at 16°C for 15 hours. After the reaction, E. coli is collected in the reaction solution.
DH1 strain was transformed and 200μg/ml of 5-brome-
4-chloro-3-indolyl-β-D-galactoside and 10 μg/ml ampicillin (Sigma)
The blue colonies that appeared were isolated. Prepare plasmid DNA from colonies, add 1 unit of restriction enzyme Hinc to 1 μg of plasmid DNA, and add 20 μg of Hind.
After reacting in the reaction solution at 37°C for 1 hour, the reaction product was analyzed on a 1.0% agarose gel. Among the analyzed plasmids, DNA fragments of 3300 base pairs, 500 base pairs, and 1300 base pairs were detected, and the plasmid was selected and named pMG1.
発現用プラスミドpMG1によるラツト肝チトク
ロムP−450cの発現
構築した発現用プラスミドpMG1を用いて、大
腸菌内でラツト肝チトクロムP−450cの発現を行
つた。以下にその詳細な方法を述べる
ステツプ1 マキシ・セル法による発現蛋白の標
識
構築したpMG1プラスミドを、Cohenらの方法
に従い、大腸菌CSR603株(uvr A6,rec Al,
phr,thr,1eu,pro,his,arg,lac,gal,ara,
xyl,mtl,str)(九州大学理学部分子遺伝学講座
保存菌株;住友化学工業株式会社、宝塚総合研究
所にても保存)に形質転換し、形質転換体
CSR603(pMG1)株を得た。得られたコロニーを
培養し、サンカー(Sancar)らのマキシセル法
(J.M.B148p45−62)に従い、発現蛋白の標識を
行た。まず、大腸菌CSR603(pMG1)株を、K培
地〔1%カザミノ酸、0.1μg/mlチアミン+M9培
地、但しM9培地は、Na2HPO46g、KH2PO43g、
NaC0.5g、NH4C1gに蒸留水を加えて1
とし、オートクレーブ後、0.01MCaC2を10ml、
1MMgSO4を1mlを加えたもの。〕中で37℃1晩
培養した。その0.1mlを10mlのK培地に植え継ぎ、
37℃でインキユベートして、OD660が0.2になるま
で増殖させた。滅菌した時計皿に10mlの培養液を
移し、15Wの紫外線ランプ直下約90cmの距離で、
5〜20秒照射した。照射後、培養液を100ml容三
角フラスコに移し、37℃で1時間培養し、サイク
ロセリンを100μg/mlになるように加え、37℃で
8〜12時間インキユベートした。3000rpmで15分
間遠心して集菌し、ハーシーソルト(5.4gNaC
,3.0gKC,1.1gNH4C,15mg CaC2・
2H2O、0.2gMgC2・6H2O,0.2mg FeC3・
6H2O,87mgKH2PO4,12.1gTrizmabase/1
)で2回洗浄した。つぎに菌を5mlのハーシ培
地〔ハーシソルト100ml当たり、0.5mlスレオニン
(2%)、1mlロイシン(1%)、1mlプロリン
(2%)、1mlアルギニン(2%)、0.1mlチアミン
(0.1%)〕に懸濁し、37℃1時間インキユベート
した。さらに35S−メチオニン(1000Ci/
mmole)を50μCi/mlになる様に加え、37℃で1
時間インキュベートした。遠心して集菌し、0.1
mlの2%SDS(ドデシル硫酸ナトリウム)に懸濁
後、100℃で4分間熱処理し、タンパク質を溶解
させた。以上のようにして、調製した粗抽出液の
25μに対して、75μの沈降用緩衝液〔25%
Triton X−100、190mM NaC,
6mMEDTA,50mMTrisHC(pH7.4)〕を加
え、抗P−450cgGを10μgを添加し、4℃で1
晩放置した。これに、T緩衝液〔2%Triton X
−100,2mM Met,150mM NaC,
5mMEDTA,50mMTris−HC(pH7.4)〕で
平衡化したProteinA−SepharoseCL−4B(フア
ルマシア社)を50μ添加し、10分ごとに攪拌し
ながら、室温で1時間反応させた。12000r.p.m.
で5分間遠心し、沈殿したゲルを1mlのT緩衝液
で2回洗浄し非特異的吸着物を除去した。得られ
たゲルを50μのサンプル緩衝液(上記)中で1
分間煮沸して、ゲルに吸着した免疫沈降物を溶出
した後、溶出液を、Laemmliらの方法
(Nature227p680−685)に従つて、SDS−ポリア
クリルアミドゲル電気泳動にかけ、フルオログラ
フイーを行つた。結果を第1図に示す。Aは対称
として用いたpAU157の例で、免疫沈降物は検出
されなかつたが、pMG1を用いたBでは、ラツト
肝チトクロムP−450cに相当する免疫沈降物が確
認された。また、その発現量は、検出量から推定
して大腸菌細胞当り、102〜103分子であると考え
られる。Expression of rat liver cytochrome P-450c using expression plasmid pMG1 Rat liver cytochrome P-450c was expressed in Escherichia coli using the constructed expression plasmid pMG1. The detailed method is described below. Step 1: Labeling of expressed protein using the maxi-cell method.
phr, thr, 1eu, pro, his, arg, lac, gal, ara,
xyl, mtl, str) (Kyushu University Department of Molecular Genetics Department; also stored at Sumitomo Chemical Co., Ltd. and Takarazuka Research Institute).
CSR603 (pMG1) strain was obtained. The obtained colonies were cultured, and the expressed protein was labeled according to the Maxixel method of Sancar et al. (JMB 148 p45-62). First, E. coli CSR603 (pMG1) strain was grown in K medium [1% casamino acids, 0.1 μg/ml thiamine + M9 medium, however, M9 medium contained 6 g of Na 2 HPO 4 , 3 g of KH 2 PO 4 ,
Add distilled water to 0.5g of NaC and 1g of NH 4 C to make 1
After autoclaving, add 10ml of 0.01MCaC2 ,
Add 1ml of 1MMgSO4. ] and cultured overnight at 37°C. Subplant 0.1ml of that into 10ml of K medium.
Incubate at 37°C and grow to an OD 660 of 0.2. Transfer 10ml of the culture solution to a sterilized watch glass and place it at a distance of about 90cm directly under a 15W ultraviolet lamp.
Irradiation was performed for 5 to 20 seconds. After irradiation, the culture solution was transferred to a 100 ml Erlenmeyer flask, cultured at 37°C for 1 hour, cycloserine was added at 100 μg/ml, and incubated at 37°C for 8 to 12 hours. Collect bacteria by centrifugation at 3000 rpm for 15 minutes, and add Hershey salt (5.4 g NaC
, 3.0gKC, 1.1gNH 4 C, 15mg CaC 2・
2H 2 O, 0.2gMgC 2・6H 2 O, 0.2mg FeC 3・
6H2O , 87mgKH2PO4 , 12.1gTrizmabase /1
) was washed twice. Next, the bacteria were grown in 5 ml of Hershey medium [per 100 ml of Hershey salt, 0.5 ml threonine (2%), 1 ml leucine (1%), 1 ml proline (2%), 1 ml arginine (2%), 0.1 ml thiamine (0.1%)]. and incubated at 37°C for 1 hour. Furthermore, 35 S-methionine (1000Ci/
mmole) to 50μCi/ml, and at 37℃
Incubated for hours. Collect bacteria by centrifugation, 0.1
After suspending the protein in 2% SDS (sodium dodecyl sulfate), it was heat-treated at 100°C for 4 minutes to dissolve the protein. The crude extract prepared as above
25μ to 75μ sedimentation buffer [25%
Triton X-100, 190mM NaC,
6mMEDTA, 50mM TrisHC (pH 7.4)], 10μg of anti-P-450cgG, and incubated at 4℃ for 1 hour.
I left it for the night. To this, add T buffer [2% Triton
−100, 2mM Met, 150mM NaC,
50μ of Protein A-Sepharose CL-4B (Pharmacia) equilibrated with 5mMEDTA, 50mM Tris-HC (pH 7.4) was added, and the mixture was allowed to react at room temperature for 1 hour while stirring every 10 minutes. 12000rpm
The precipitated gel was washed twice with 1 ml of T buffer to remove non-specifically adsorbed substances. The resulting gel was incubated in 50μ sample buffer (above) for 1 hour.
After boiling for minutes to elute the immunoprecipitate adsorbed to the gel, the eluate was subjected to SDS-polyacrylamide gel electrophoresis and fluorography according to the method of Laemmli et al. (Nature 227p680-685). The results are shown in Figure 1. A is an example of pAU157 used as a control, and no immunoprecipitate was detected, but in B, using pMG1, an immunoprecipitate corresponding to rat liver cytochrome P-450c was confirmed. Furthermore, the expression level is estimated to be 10 2 to 10 3 molecules per E. coli cell, estimated from the detected amount.
以上のことから、大腸菌CSR603株に組換え体
プラスミドpMG1を導入することにより、ラツト
肝チトクロムP−450c蛋白が発現することが確認
された。 From the above, it was confirmed that rat liver cytochrome P-450c protein was expressed by introducing the recombinant plasmid pMG1 into E. coli strain CSR603.
第1図は、ラツト肝チトクロムP−450c蛋白の
大腸菌内での発現量を示すフルオログラフイー結
果を示す。
FIG. 1 shows fluorography results showing the expression level of rat liver cytochrome P-450c protein in E. coli.
Claims (1)
養することを特徴とするラツト肝チトクロムP−
450cの製造方法。1. Rat liver cytochrome P-, which is characterized by culturing E. coli transformed with plasmid pMG1.
How to make 450c.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25543090A JPH03172175A (en) | 1984-06-16 | 1990-09-27 | Production of rat liver cytochrome p-450c |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12295284A JPS615783A (en) | 1984-06-16 | 1984-06-16 | Expression plasmid aiming at expression of rat hepatic cytochrome p-450mc gene in escherichia coli |
| JP25543090A JPH03172175A (en) | 1984-06-16 | 1990-09-27 | Production of rat liver cytochrome p-450c |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP12295284A Division JPS615783A (en) | 1984-06-16 | 1984-06-16 | Expression plasmid aiming at expression of rat hepatic cytochrome p-450mc gene in escherichia coli |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH03172175A JPH03172175A (en) | 1991-07-25 |
| JPH0523743B2 true JPH0523743B2 (en) | 1993-04-05 |
Family
ID=26459991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP25543090A Granted JPH03172175A (en) | 1984-06-16 | 1990-09-27 | Production of rat liver cytochrome p-450c |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH03172175A (en) |
-
1990
- 1990-09-27 JP JP25543090A patent/JPH03172175A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPH03172175A (en) | 1991-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4581335A (en) | Process for producing a cloned luciferase-synthesizing microorganism | |
| US5143844A (en) | Construction of an igg binding protein to facilitate downstream processing using protein engineering | |
| CN103906833B (en) | Protein expression | |
| JPH0759193B2 (en) | Cloning vector for foreign protein expression | |
| CN110592058A (en) | Threonine aldolase, coding gene thereof and application of threonine aldolase in droxidopa biosynthesis | |
| CS250655B2 (en) | Method of microorganisme's viable culture's cultivation with means content for asexual regeneration | |
| JPH0665305B2 (en) | Method for stabilizing host cell containing recombinant DNA | |
| CN107858340B (en) | D-fructose-6-phosphate aldolase A mutant with high catalytic activity, recombinant expression vector, genetically engineered bacteria and its application | |
| JP2842693B2 (en) | Methods and DNA expression systems for overexpression of proteins in host cells | |
| CN106701723A (en) | D-fructose-6-phosphate aldolase A mutant, recombinant expression vector, genetically engineered bacterium and application and reaction product thereof | |
| Sancar et al. | Purification and characterization of DNA photolyases | |
| CN115873813A (en) | Method for synthesizing boldenone through enzyme catalysis cascade | |
| JPH0523743B2 (en) | ||
| JPH047193B2 (en) | ||
| JPS5951793A (en) | New cloning vehicle | |
| JPH0429352B2 (en) | ||
| KR100462832B1 (en) | Gene for Cell-surface Expression | |
| JPS61181386A (en) | Novel development regulating arrangement | |
| KR910001811B1 (en) | Method for control of foreign gene expression by glucose | |
| JPH07108225B2 (en) | D-amino acid oxidase gene | |
| JPS62262994A (en) | D-amino acid oxidase gene | |
| CN120118913B (en) | A nucleic acid molecule encoding human defensin and a method for preparing human defensin and its application | |
| CN119842663B (en) | A carboxylesterase mutant and its application in producing (R)-3-cyclohexene-1-carboxylic acid | |
| KR102075740B1 (en) | A Novel Soluble Methane Monooxygenase Identified By High-Throughput Enzyme Screening System | |
| JPH0636744B2 (en) | Chimeric cytochrome P-450 gene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |